- Secured a total of 55 million in R&D funding, including 40 million in upfront payment and 15 million in equity investment - Accelerating R&D on core technologies, including expansion of indications for the Grabody platform SEOUL, South Korea, Dec. 25, 2025 /PRNewswire/ -- ABL Bio (CEO...
Hence then, the article about abl bio receives upfront payment for license research and collaboration agreement for grabody platform and equity investment from lilly was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( ABL Bio Receives Upfront Payment for License, Research and Collaboration Agreement for Grabody Platform and Equity Investment from Lilly )
Also on site :
- One person in critical condition following two-vehicle collision on SR-126 at Boosey Road
- Kentucky congressman announces death of longtime staffer, campaign manager
- Man injured after jumping from upper floors of Grand Mosque in Makkah